Accredited Investors Inc. Abbott Laboratories Transaction History

Accredited Investors Inc.

  • $1.68 Billion
  • Q3 2024

A detailed history of Accredited Investors Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Accredited Investors Inc. holds 13,788 shares of ABT stock, worth $1.62 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
13,788
Previous 13,788 -0.0%
Holding current value
$1.62 Million
Previous $1.57 Million -0.0%
% of portfolio
0.09%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
BUY
$100.07 - $118.13 $106,274 - $125,454
1,062 Added 8.35%
13,788 $1.57 Million
Q2 2024

Jul 19, 2024
BUY
$100.73 - $112.44 $114,227 - $127,506
1,134 Added 9.78%
12,726 $1.32 Million
Q1 2024

May 14, 2024
SELL
$109.52 - $120.96 $1,423 - $1,572
-13 Reduced 0.11%
11,592 $1.32 Million
Q4 2023

Feb 07, 2024
BUY
$90.19 - $110.4 $270 - $331
3 Added 0.03%
11,605 $1.28 Million
Q3 2023

Nov 07, 2023
SELL
$95.53 - $114.62 $12,609 - $15,129
-132 Reduced 1.12%
11,602 $1.12 Million
Q2 2023

Aug 03, 2023
SELL
$100.78 - $112.29 $166,690 - $185,727
-1,654 Reduced 12.35%
11,734 $1.28 Million
Q1 2023

Apr 24, 2023
BUY
$96.86 - $114.01 $290 - $342
3 Added 0.02%
13,388 $1.36 Million
Q4 2022

Feb 07, 2023
BUY
$95.06 - $111.52 $68,253 - $80,071
718 Added 5.67%
13,385 $1.47 Million
Q3 2022

Nov 08, 2022
BUY
$96.76 - $112.03 $22,351 - $25,878
231 Added 1.86%
12,667 $1.23 Million
Q2 2022

Jul 21, 2022
SELL
$102.07 - $123.37 $42,767 - $51,692
-419 Reduced 3.26%
12,436 $1.35 Million
Q1 2022

May 06, 2022
SELL
$114.02 - $139.04 $22,005 - $26,834
-193 Reduced 1.48%
12,855 $1.52 Million
Q4 2021

Jan 31, 2022
SELL
$115.53 - $141.46 $50,371 - $61,676
-436 Reduced 3.23%
13,048 $1.84 Million
Q3 2021

Nov 12, 2021
BUY
$116.66 - $129.06 $17,732 - $19,617
152 Added 1.14%
13,484 $1.59 Million
Q2 2021

Jul 30, 2021
BUY
$105.79 - $124.53 $211 - $249
2 Added 0.02%
13,332 $1.55 Million
Q1 2021

Apr 16, 2021
SELL
$108.84 - $128.23 $94,473 - $111,303
-868 Reduced 6.11%
13,330 $1.6 Million
Q4 2020

Feb 11, 2021
BUY
$105.0 - $114.42 $89,985 - $98,057
857 Added 6.42%
14,198 $1.56 Million
Q3 2020

Nov 05, 2020
SELL
$91.64 - $111.29 $63,964 - $77,680
-698 Reduced 4.97%
13,341 $1.45 Million
Q2 2020

Jul 29, 2020
SELL
$76.57 - $98.0 $25,114 - $32,144
-328 Reduced 2.28%
14,039 $1.28 Million
Q1 2020

May 15, 2020
BUY
$62.82 - $91.86 $2,073 - $3,031
33 Added 0.23%
14,367 $1.13 Million
Q4 2019

Jan 23, 2020
BUY
$78.51 - $87.4 $157 - $174
2 Added 0.01%
14,334 $1.25 Million
Q3 2019

Nov 14, 2019
SELL
$81.84 - $88.74 $38,628 - $41,885
-472 Reduced 3.19%
14,332 $1.2 Million
Q2 2019

Aug 13, 2019
SELL
$72.88 - $85.0 $48,246 - $56,270
-662 Reduced 4.28%
14,804 $0
Q1 2019

Apr 17, 2019
BUY
$66.22 - $80.06 $473,605 - $572,589
7,152 Added 86.02%
15,466 $1.24 Million
Q4 2018

Feb 13, 2019
BUY
$65.56 - $74.27 $168,095 - $190,428
2,564 Added 44.59%
8,314 $601,000
Q3 2018

Oct 23, 2018
BUY
$60.81 - $73.36 $27,486 - $33,158
452 Added 8.53%
5,750 $422,000
Q2 2018

Jul 31, 2018
SELL
$57.57 - $63.54 $11,514 - $12,708
-200 Reduced 3.64%
5,298 $323,000
Q1 2018

Apr 18, 2018
BUY
$56.27 - $63.62 $18,175 - $20,549
323 Added 6.24%
5,498 $329,000
Q4 2017

Jan 17, 2018
BUY
$53.68 - $57.47 $21,364 - $22,873
398 Added 8.33%
5,175 $295,000
Q3 2017

Oct 30, 2017
BUY
$48.06 - $53.64 $229,582 - $256,238
4,777
4,777 $255,000

Others Institutions Holding ABT

# of Institutions
3,185
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $205B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Accredited Investors Inc. Portfolio

Follow Accredited Investors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email